Literature DB >> 10101220

Modulating apoptosis: current applications and prospects for future drug development.

H P Deigner1, R Kinscherf.   

Abstract

Agents modulating apoptosis are of extraordinary promise for the treatment of several states of disease including cancer, AIDS, neurodegenerative and ischemic diseases. In this review a brief summary of cellular pathways relevant to programmed cell death first is given and potential therapeutic targets therein are emphasized. Current efforts in drug development are discussed from a mechanistic, biochemical point of view and pro- and anti-apoptotic strategies are related to the respective diseases. Therapeutic approaches addressed in this paper include the design and activity of novel low molecular weight agents (e.g. caspase inhibitors) as well as gene therapy (e.g. p53, adenovirus as vector in cancer treatment). In final sections, the latest findings in the field of apoptosis are highlighted and future applications are outlined.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10101220

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  6 in total

1.  A new method for evaluating sigma(2) ligand activity in the isolated guinea-pig bladder.

Authors:  Nicola A Colabufo; Francesco Berardi; Marialessandra Contino; Roberto Perrone; Vincenzo Tortorella
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-17       Impact factor: 3.000

2.  Assessment of the cytotoxic effects of aporphine prototypes on head and neck cancer cells.

Authors:  Dorival Mendes Rodrigues-Junior; Nicolie Melanie de Almeida Pontes; Gabriela Estrela de Albuquerque; Viviane Carlin; Givago Prado Perecim; Cristiano Raminelli; André Luiz Vettore
Journal:  Invest New Drugs       Date:  2019-05-17       Impact factor: 3.850

3.  Assessment of the antitumor potential of Bithionol in vivo using a xenograft model of ovarian cancer.

Authors:  Vijayalakshmi N Ayyagari; Nancy A Johnston; Laurent Brard
Journal:  Anticancer Drugs       Date:  2016-07       Impact factor: 2.248

4.  Antioxidant activity and ultrastructural changes in gastric cancer cell lines induced by Northeastern Thai edible folk plant extracts.

Authors:  Praphaporn Stewart; Patcharee Boonsiri; Songchan Puthong; Panadda Rojpibulstit
Journal:  BMC Complement Altern Med       Date:  2013-03-13       Impact factor: 3.659

5.  Bithionol inhibits ovarian cancer cell growth in vitro - studies on mechanism(s) of action.

Authors:  Vijayalakshmi N Ayyagari; Laurent Brard
Journal:  BMC Cancer       Date:  2014-02-04       Impact factor: 4.430

Review 6.  The Role of Resveratrol in Cancer Therapy.

Authors:  Jeong-Hyeon Ko; Gautam Sethi; Jae-Young Um; Muthu K Shanmugam; Frank Arfuso; Alan Prem Kumar; Anupam Bishayee; Kwang Seok Ahn
Journal:  Int J Mol Sci       Date:  2017-12-01       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.